Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities
Net income	$ 11,038,000	$ 11,870,000
Adjustments to reconcile net income to net cash from operating activities
Depreciation and amortization	4,734,000	1,629,000
Accretion of acquired loans	(1,687,000)	0
Provision for loan losses	(3,000,000)	(4,700,000)
Stock-based compensation expense	364,000	354,000
Proceeds from sales of mortgage loans held for sale	41,246,000	43,789,000
Origination of mortgage loans held for sale	(40,481,000)	(41,147,000)
Net gain from sales of mortgage loans held for sale	(935,000)	(550,000)
Net gain from sales and valuation write-down of foreclosed assets	(721,000)	(1,024,000)
Earnings on bank owned life insurance	(880,000)	(1,025,000)
Net change in:
Accrued interest receivable	(269,000)	97,000
Other assets	184,000	13,451,000
Accrued interest and other liabilities	(5,155,000)	(776,000)
Net cash from operating activities	4,438,000	21,968,000
Cash flows from investing activities
Cash received in merger	91,806,000	0
Loan originations and payments, net	(70,034,000)	(37,232,000)
Purchases of securities available for sale	(14,379,000)	(37,492,000)
Proceeds from maturities, calls and repayments of securities available for sale	46,445,000	31,578,000
Proceeds from sales of securities available for sale	0	10,310,000
Proceeds from sales of foreclosed assets	3,184,000	6,505,000
Purchases of premises and equipment	(1,167,000)	(250,000)
Net cash from (for) investing activities	55,855,000	(26,581,000)
Cash flows from financing activities
Net decrease in time deposits	(40,963,000)	(13,871,000)
Net increase (decrease) in all other deposits	(35,065,000)	176,000
Net increase in securities sold under agreements to repurchase	19,080,000	915,000
Proceeds from Federal Home Loan Bank advances	0	10,000,000
Net increase in other borrowed money	3,894,000	107,000
Proceeds from stock option exercises	229,000	0
Employee stock purchase plan	10,000	19,000
Dividend reinvestment plan	90,000	33,000
Stock grants to directors for retainer fee	155,000	0
Payment of cash dividends to common shareholders	(22,436,000)	(2,851,000)
Net cash for financing activities	(75,006,000)	(5,472,000)
Net change in cash and cash equivalents	(14,713,000)	(10,085,000)
Cash and cash equivalents at beginning of period	146,965,000	136,003,000
Cash and cash equivalents at end of period	132,252,000	125,918,000
Cash paid during the period for:
Interest	8,574,000	8,779,000
Federal income tax	1,575,000	0
Noncash financing and investing activities:
Transfers from loans to foreclosed assets	$ 1,084,000	$ 2,060,000